Cade Richesin
Researcher
Also affiliated: Washington Regional Medical Center (2025)
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Cade Richesin's research focuses on the intersection of cancer biology and treatment modalities. His recent publications investigate the comparative efficacy of CAR T-cell therapy and bispecific antibodies in treating B-cell lymphomas, analyzing long-term outcomes, durability, safety, and toxicity profiles. Additionally, Richesin's work explores how melanoma tumor cells and immunotherapy can collaboratively alter bone marrow niches, leading to early hematopoietic dysfunction and the development of therapy-related myeloid neoplasms. He has co-authored two publications with Chinemerem Emeasoba from the University of Arkansas at Fayetteville.
Metrics
- Publications: 2
Selected Publications
-
1073 Battle of the biologics a head to head review of CAR T cell therapy versus bispecific antibodies in B cell lymphomas balancing long term efficacy durability safety and toxicity profiles (2025)
Collaboration Network
Top Collaborators
- 1073 Battle of the biologics a head to head review of CAR T cell therapy versus bispecific antibodies in B cell lymphomas balancing long term efficacy durability safety and toxicity profiles
- 1073 Battle of the biologics a head to head review of CAR T cell therapy versus bispecific antibodies in B cell lymphomas balancing long term efficacy durability safety and toxicity profiles
- 1073 Battle of the biologics a head to head review of CAR T cell therapy versus bispecific antibodies in B cell lymphomas balancing long term efficacy durability safety and toxicity profiles
Similar Researchers
Based on overlapping research topics